Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Oct;39(10):2243–2247. doi: 10.1128/aac.39.10.2243

In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood.

F Alcaide 1, J Liñares 1, R Pallares 1, J Carratala 1, M A Benitez 1, F Gudiol 1, R Martin 1
PMCID: PMC162923  PMID: 8619576

Abstract

A total of 410 strains of viridans group streptococci isolated consecutively from blood were tested by the microdilution method for in vitro susceptibility to 22 beta-lactam antibiotics. One hundred thirty-eight strains (33.6%) were resistant to penicillin with a MIC range of 0.25 to 8 micrograms/ml. MICs of all beta-lactam agents tested were higher for penicillin-resistant strains than for susceptible strains. These antibiotics were classified into three groups according to their in vitro activities (MICs at which 50 and 90% of the isolates are inhibited). Beta-Lactams of the first group (these included imipenem, cefpirome, FK-037, cefditoren, cefotaxime, ceftriaxone, and cefepime) showed activities higher than or similar to that of penicillin against penicillin-resistant viridans group streptococci. However, 80% of highly penicillin-resistant Streptococcus mitis organisms required cefotaxime and ceftriaxone MICs of > or = 2 micrograms/ml (range, 2 to 16 micrograms/ml). Beta-Lactams of the second group (cefpodoxime, ampicillin, amoxicillin-clavulanate, piperacillin, and cefuroxime) showed lower activities than penicillin. Finally, antibiotics of the third group (cephalothin, oxacillin, ceftazidime, cefixime, cefaclor, cefetamet, cefadroxil, cephalexin, and ceftibuten) showed poor in vitro activities. Therefore, some of the beta-lactam agents included in the first group could be an acceptable alternative in the treatment of serious infections due to strains highly resistant to penicillin, although clinical experience is needed.

Full Text

The Full Text of this article is available as a PDF (211.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Awada A., van der Auwera P., Meunier F., Daneau D., Klastersky J. Streptococcal and enterococcal bacteremia in patients with cancer. Clin Infect Dis. 1992 Jul;15(1):33–48. doi: 10.1093/clinids/15.1.33. [DOI] [PubMed] [Google Scholar]
  2. Brandenburg R. O., Giuliani E. R., Wilson W. R., Geraci J. E. Infective endocarditis--a 25 year overview of diagnosis and therapy. J Am Coll Cardiol. 1983 Jan;1(1):280–291. doi: 10.1016/s0735-1097(83)80029-1. [DOI] [PubMed] [Google Scholar]
  3. Broughton R. A., Krafka R., Baker C. J. Non-group D alpha-hemolytic streptococci: new neonatal pathogens. J Pediatr. 1981 Sep;99(3):450–454. doi: 10.1016/s0022-3476(81)80347-2. [DOI] [PubMed] [Google Scholar]
  4. Burden A. D., Oppenheim B. A., Crowther D., Howell A., Morgenstern G. R., Scarffe J. H., Thatcher N. Viridans streptococcal bacteraemia in patients with haematological and solid malignancies. Eur J Cancer. 1991;27(4):409–411. doi: 10.1016/0277-5379(91)90373-l. [DOI] [PubMed] [Google Scholar]
  5. Carratalá J., Alcaide F., Fernández-Sevilla A., Corbella X., Lińares J., Gudiol F. Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer. Clin Infect Dis. 1995 May;20(5):1169–1173. doi: 10.1093/clinids/20.5.1169. [DOI] [PubMed] [Google Scholar]
  6. Chalkley L., Schuster C., Potgieter E., Hakenbeck R. Relatedness between Streptococcus pneumoniae and viridans streptococci: transfer of penicillin resistance determinants and immunological similarities of penicillin-binding proteins. FEMS Microbiol Lett. 1991 Dec 15;69(1):35–42. doi: 10.1016/0378-1097(91)90642-n. [DOI] [PubMed] [Google Scholar]
  7. Chen S. C., Sorrell T. C., Dwyer D. E., Collignon P. J., Wright E. J. Endocarditis associated with prosthetic cardiac valves. Med J Aust. 1990 May 7;152(9):458, 461-3. doi: 10.5694/j.1326-5377.1990.tb125303.x. [DOI] [PubMed] [Google Scholar]
  8. Coykendall A. L. Classification and identification of the viridans streptococci. Clin Microbiol Rev. 1989 Jul;2(3):315–328. doi: 10.1128/cmr.2.3.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dowson C. G., Hutchison A., Woodford N., Johnson A. P., George R. C., Spratt B. G. Penicillin-resistant viridans streptococci have obtained altered penicillin-binding protein genes from penicillin-resistant strains of Streptococcus pneumoniae. Proc Natl Acad Sci U S A. 1990 Aug;87(15):5858–5862. doi: 10.1073/pnas.87.15.5858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Farber B. F., Eliopoulos G. M., Ward J. I., Ruoff K. L., Syriopoulou V., Moellering R. C., Jr Multiply resistant viridans streptococci: susceptibility to beta-lactam antibiotics and comparison of penicillin-binding protein patterns. Antimicrob Agents Chemother. 1983 Nov;24(5):702–705. doi: 10.1128/aac.24.5.702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fenoll A., Martín Bourgon C., Muñz R., Vicioso D., Casal J. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev Infect Dis. 1991 Jan-Feb;13(1):56–60. doi: 10.1093/clinids/13.1.56. [DOI] [PubMed] [Google Scholar]
  12. Francioli P. B., Glauser M. P. Synergistic activity of ceftriaxone combined with netilmicin administered once daily for treatment of experimental streptococcal endocarditis. Antimicrob Agents Chemother. 1993 Feb;37(2):207–212. doi: 10.1128/aac.37.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Francioli P., Etienne J., Hoigné R., Thys J. P., Gerber A. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility. JAMA. 1992 Jan 8;267(2):264–267. [PubMed] [Google Scholar]
  14. Goldfarb J., Wormser G. P., Glaser J. H. Meningitis caused by multiply antibiotic-resistant viridans streptococci. J Pediatr. 1984 Dec;105(6):891–895. doi: 10.1016/s0022-3476(84)80072-4. [DOI] [PubMed] [Google Scholar]
  15. Gossling J. Occurrence and pathogenicity of the Streptococcus milleri group. Rev Infect Dis. 1988 Mar-Apr;10(2):257–285. doi: 10.1093/clinids/10.2.257. [DOI] [PubMed] [Google Scholar]
  16. Hakenbeck R., Ellerbrok H., Briese T., Handwerger S., Tomasz A. Penicillin-binding proteins of penicillin-susceptible and -resistant pneumococci: immunological relatedness of altered proteins and changes in peptides carrying the beta-lactam binding site. Antimicrob Agents Chemother. 1986 Oct;30(4):553–558. doi: 10.1128/aac.30.4.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lipsky B. A., Pecoraro R. E., Ahroni J. H., Peugeot R. L. Immediate and long-term efficacy of systemic antibiotics for eradicating nasal colonization with Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 1992 Jan;11(1):43–47. doi: 10.1007/BF01971270. [DOI] [PubMed] [Google Scholar]
  18. Mansur A. J., Grinberg M., Gallucci S. D., Bellotti G., Jatene A., Pileggi F. Endocardite infecciosa: análise de 300 episódios. Arq Bras Cardiol. 1990 Jan;54(1):13–21. [PubMed] [Google Scholar]
  19. McWhinney P. H., Patel S., Whiley R. A., Hardie J. M., Gillespie S. H., Kibbler C. C. Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin. Antimicrob Agents Chemother. 1993 Nov;37(11):2493–2495. doi: 10.1128/aac.37.11.2493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. NAIMAN R. A., BARROW J. G. Pencillin-resistant bacteria in the mouths and throats of children receiving continuous prophylaxis against rheumatic fever. Ann Intern Med. 1963 May;58:768–772. doi: 10.7326/0003-4819-58-5-768. [DOI] [PubMed] [Google Scholar]
  21. Piscitelli S. C., Shwed J., Schreckenberger P., Danziger L. H. Streptococcus milleri group: renewed interest in an elusive pathogen. Eur J Clin Microbiol Infect Dis. 1992 Jun;11(6):491–498. doi: 10.1007/BF01960802. [DOI] [PubMed] [Google Scholar]
  22. Potgieter E., Chalkley L. J. Reciprocal transfer of penicillin resistance genes between Streptococcus pneumoniae, Streptococcus mitior and Streptococcus sanguis. J Antimicrob Chemother. 1991 Sep;28(3):463–465. doi: 10.1093/jac/28.3.463. [DOI] [PubMed] [Google Scholar]
  23. Quinn J. P., DiVincenzo C. A., Lucks D. A., Luskin R. L., Shatzer K. L., Lerner S. A. Serious infections due to penicillin-resistant strains of viridans streptococci with altered penicillin-binding proteins. J Infect Dis. 1988 Apr;157(4):764–769. doi: 10.1093/infdis/157.4.764. [DOI] [PubMed] [Google Scholar]
  24. Ruoff K. L. Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen. Clin Microbiol Rev. 1988 Jan;1(1):102–108. doi: 10.1128/cmr.1.1.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Santini C., Venditti M., Baiocchi P., Brandimarte C., Serra P., Mandelli F., Girmenia C., Micozzi A., Martino P. Emergence of penicillin-resistant viridans streptococci causing septicemia in granulocytopenic patients. Eur J Epidemiol. 1988 Sep;4(3):391–392. doi: 10.1007/BF00148932. [DOI] [PubMed] [Google Scholar]
  26. Watanakunakorn C., Burkert T. Infective endocarditis at a large community teaching hospital, 1980-1990. A review of 210 episodes. Medicine (Baltimore) 1993 Mar;72(2):90–102. doi: 10.1097/00005792-199303000-00003. [DOI] [PubMed] [Google Scholar]
  27. Whiley R. A., Beighton D., Winstanley T. G., Fraser H. Y., Hardie J. M. Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections. J Clin Microbiol. 1992 Jan;30(1):243–244. doi: 10.1128/jcm.30.1.243-244.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. van der Meer J. T., van Vianen W., Hu E., van Leeuwen W. B., Valkenburg H. A., Thompson J., Michel M. F. Distribution, antibiotic susceptibility and tolerance of bacterial isolates in culture-positive cases of endocarditis in The Netherlands. Eur J Clin Microbiol Infect Dis. 1991 Sep;10(9):728–734. doi: 10.1007/BF01972497. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES